Feasibility of Reduced-Intensity Cord Blood Transplantation as Salvage Therapy for Graft Failure: Results of a Nationwide Survey of Adult Patients

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 6, 2011, Pages 841-851

  Waki, Fusako ^a   Masuoka, Kazuhiro ^b   Fukuda, Takahiro ^a   Kanda, Yoshinobu ^c   Nakamae, Mika ^d   Yakushijin, Kimikazu ^e   Togami, Katsuhiro ^f   Nishiwaki, Kaichi ^g   Ueda, Yasunori ^h   Kawano, Fumio ⁱ   Kasai, Masaharu ^j   Nagafuji, Koji ^k   Hagihara, Maki ^l   Hatanaka, Kazuo ^m   Taniwaki, Masafumi ⁿ   Maeda, Yoshinobu ^o   Shirafuji, Naoki ^p   Mori, Takehiko ^q   Utsunomiya, Atae ^r   Eto, Tetsuya ^s   Nakagawa, Hitoshi ^t   Murata, Makoto ^u   Uchida, Toshiki ^v   Iida, Hiroatsu ^w   Yakushiji, Kazuaki ^x   Yamashita, Takuya ^y   Wake, Atsushi ^b   Takahashi, Satoshi ^z   Takaue, Yoichi ^a   Taniguchi, Shuichi ^b   more..

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KURASHIKI CENTRAL HOSPITAL   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^j SAPPORO HOKUYU HOSPITAL   (Japan)

^k KYUSHU UNIVERSITY   (Japan)

^l KANAGAWA CANCER CENTER   (Japan)

^m Department of Cardiology   (Japan)

ⁿ KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^o OKAYAMA UNIVERSITY   (Japan)

^p TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r IMAMURA BUN IN HOSPITAL   (Japan)

^s HAMANOMACHI HOSPITAL   (Japan)

^t KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^u NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^v NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^w Meitetsu Hospital   (Japan)

^x KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^y TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^z UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Allogeneic stem cell transplantation; Cord blood transplantation; Graft failure; Reduced intensity; Rejection

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GRAFT FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY; SURVIVAL; TRANSPLANTATION; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; BUSULFAN; CORD BLOOD STEM CELL TRANSPLANTATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE COUNT; MALE; MELPHALAN; MULTIVARIATE ANALYSIS; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 79956004870     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.09.005     Document Type: Article

References (51)

1. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989, 321:1174-1178.
2. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft versus host disease. Blood 1996, 88:795-802.
3. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 patients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
4. Laughlin M.J., Barker J., Bambach B., et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood form unrelated-donors. N Engl J Med 2001, 344:1815-1822.
5. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004, 351:2265-2275.
6. Schoemans H., Theunissen K., Maertens J., et al. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant 2006, 38:83-93.
7. Aversa F., Terenzi A., Tabilio A., et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005, 23:3447-3454.
8. Giralt S., Estey E., Albitar M., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997, 89:4531-4536.
9. Slavin S., Nagler A., Naparstek E., et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998, 91:756-763.
10. Childs R., Clave E., Contentin N., et al. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999, 94:3234-3241.
11. McSweeney P.A., Neiserwieser D., Shizuru J.A., et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001, 97:3390-3400.
12. Maris M.B., Niederwieser D., Sandmaier B.M., et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003, 102:2021-2030.
13. Shaw B.E., Russell N.H., Devereux S., et al. The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. Haematologica 2005, 90:1562-1569.
14. Anasetti C., Amos D., Beatty P.G., et al. Effect of HLA compatibility on engraftment of bone marrow transplantation in patients with leukemia or lymphoma. N Engl J Med 1989, 320:197-204.
15. Petersdorf E.W., Hansen J.A., Martin P.J., et al. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med 2001, 345:1794-1800.
16. Morishima Y., Sasazuki T., Inoko H., et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002, 99:4200-4206.
17. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004, 351:2276-2285.
18. Takahashi S., Iseki T., Ooi J., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004, 104:3813-3820.
19. McCann S.R., Bacigalupo A., Gluckman E., et al. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the aplastic anaemia working party of the European bone marrow transplant group. Bone Marrow Transplant 1994, 13:233-237.
20. Davies S.M., Weisdorf D.J., Haake R.J., et al. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 14:73-77.
21. Storb R., Weiden P.L., Sullivan K.M., et al. Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 1987, 70:116-121.
22. Guardiola P., Kuentz M., Garban F., et al. Second early allogeneic stem cell transplantation for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. Br J Haematol 2000, 111:292-302.
23. Remberger M., Ringden O., Ljungman P., et al. Booster marrow or blood cell for graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 22:73-78.
24. Larocca A., Piaggio G., Podesta M., et al. A boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 2006, 91:935-940.
25. Grandage V.L., Cornish J.M., Pamphilon D.H., et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow. Bone Marrow Transplant 1998, 21:687-690.
26. Kernan N.A., Bordignon C., Heller G., et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989, 74:2227-2236.
27. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transplant 2002, 29:545-552.
28. Barker J.N., Krepski T.P., DeFor T.E., et al. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002, 8:257-260.
29. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Rapid and complete chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003, 102:1915-1919.
30. Miyakoshi S., Yuji K., Kami M., et al. Successful engraftment after reduced-intensity umbilical cord blood with advanced hematological diseases. Clin Cancer Res 2004, 10:3586-3592.
31. Khorshid O., de Meis E., Marin T., et al. Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant. Leukemia 2003, 17:2538-2540.
32. Ohwada C., Nakaseko C., Ozawa S., et al. Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML. Bone Marrow Transplantat 2004, 34:999-1000.
33. Tomonari A., Takahashi S., Shimohakamada Y., et al. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia. Bone Marrow Transplant 2005, 36:261-262.
34. Narimatsu H., Kami M., Miyakoshi S., et al. Graft failure following reduced-intensity cord blood transplantation for adult patients. Br J Haematol 2006, 132:36-41.
35. Shimada K., Narimatsu H., Morishita Y., et al. Severe regimen-related toxicity of second transplantation for graft failure following reduced-intensity cord blood transplantation in an adult patient. Bone Marrow Transplant 2006, 37:787-788.
36. Kawamori Y., Yakushijin K., Okamura A., et al. Successful engraftment in reduced-intensity cord blood transplantation (CBT) as a salvage therapy for graft failure after primary CBT in adults. Transplantation 2007, 83:1281-1282.
37. Giralt S. Reduced-intensity conditioning regimen for hematologic malignancies: what have we learned over the last 10 years?. Hematology 2005, 384-389.
38. Thiede C., Bornhauser M., Ehuinger G. Chimerism diagnosis after allogeneic hematopoietic stem cell transplantation. Acta Haematol 2004, 112:16-23.
39. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
40. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
41. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995, 15:825-828.
42. Barker J.N., Scaradavou A., Stevens C.E., Rubinstein P. Analysis of 608 umbilical cord blood (UCB) transplants: HLA-match is a critical determinant of transplant-related mortality (TRM) in the post-engraftment period even in the absence of acute graft-vs-host disease (aGVHD). Blood 2005, 106:92a-93a. (Abstract 303).
43. Barker J.N., Weisdorf D.J., DeFor T.E., et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005, 105:1343-1347.
44. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant disease: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
45. Murphy W.J., Koh C.Y., Raxiuddin A., Bennett M., Longo D.L. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 2001, 181:279-289.
46. Deeg H.J., Amylon M.D., Harris R.E., et al. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. Biol Blood Marrow Transplanat 2001, 7:208-215.
47. Narimatsu H., Matsumura T., Kami M., et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005, 11:429-436.
48. Bishton M., Chopra R. The role of granulocyte transfusions in neutropenic patients. Br J Haematol 2004, 127:501-508.
49. Tanaka T., Matsubara H., Adachi S., et al. Second transplantation from HLA 2-loci-mismatched mother for graft failure because of hemophagocytic syndrome after cord blood transplantation. Int J Hematol 2004, 80:467-469.
50. Lang P., Muller I., Greil J., et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis 2008, 40:33-39.
51. Rondon G., Saliba R.M., Khouri I., et al. Long-term follow-up of patinets who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis. Biol Blood Marrow Transplant 2008, 14:859-866.